Leading pain researchers at City St George’s, University of London are partnering with Paradigm Biopharmaceuticals, an Australian late-stage clinical development company, to test a drug that could ...

How LLM agents present AI software engineering workflows of the future, and whether the focus of programming will shift from ...

Reimaging professional and educational practices for an AI-augmented future.

This Collection provides updated research from Future Computing 2025. This collection will open for submission on 15th June. Papers intended for presentation at the 11th International Conference on ...

CMS intends to use the $1.2 trillion in provider payment it controls to push whole menu of value-based care programs.

Acurx is launching a ground-breaking clinical trial with ibezapolstat in patients with multiply-recurrent CDI (rCDI) that has the potential to shift the paradigm of treatment and prevention of rCDI ...

The modern university landscape is undergoing a profound paradigm shift. For decades, the success of higher education was measured predominantly by academic output and the transition of students into ...

Across 2026, The Brain Song reviews have ignited a new discussion inside the neuroscience community: can sound frequencies alone sharpen memory, boost focus, and help the aging brain stay alert? For ...

PrimeC into a late-stage clinical asset with FDA-cleared Phase 3 program in ALS -- Statistically significant survival benefit demonstrated, including 65% reduction in risk of death and >14-month ...

Dissection: Iran is reviewing the a 15-point ceasefire plan put forward by the U.S. Newsweek slices through it point by point ...